Left main stenting, a short and intermediate follow-up

BackgroundSignificant left main coronary artery disease occurs in about 5–7% of patients undergoing coronary angiography. Coronary artery bypass graft (CABG) surgery was the standard acceptable way in treating these lesions. The introduction of drug eluting stents (DES) in mid 2003 has pushed the rate of clinical restenosis below 5% for most lesion types. This encourged the cardiologists to treat the LMCA with DES.Methods and resultsWe implanted DES in 30 patients with denovo LMCA-Stenosis (middle age 69.9±12.5 83% men). 25 patients (83%) had hypertension, 5 diabetes mellitus (17%), 22 hyperlipidemia (73.3%) and 16 were smokers (53.3%). We implanted Paclitaxel-Stents in 26 (87%) and 4 Sirolimus-Stents (13%). 11 patients (37%) with Stents